Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma

被引:1
|
作者
Wo, Yang [1 ,2 ,3 ]
Peng, Yizhou [1 ,2 ,3 ]
Wu, Zhigang [1 ,2 ,3 ]
Liu, Pengcheng [1 ,2 ,3 ]
Shang, Yan [1 ,2 ,3 ]
Shen, Xuxia [4 ,5 ,7 ]
Sun, Yihua [1 ,2 ,3 ,6 ]
机构
[1] Fudan Univ Shanghai Canc Ctr, State Key Lab Genet Engn, Shanghai, Peoples R China
[2] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
[3] Fudan Univ, Inst Thorac Oncol, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[5] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China
[6] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China
[7] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 11期
基金
中国国家自然科学基金;
关键词
nomogram; prognostic factor; radiotherapy; SEER; STAGING PROJECT PROPOSALS; FORTHCOMING 8TH EDITION; MODULATED RADIATION-THERAPY; EXTRAPLEURAL PNEUMONECTOMY; IASLC MESOTHELIOMA; TNM CLASSIFICATION; HEMITHORACIC RADIOTHERAPY; PROGNOSTIC-FACTORS; DESCRIPTORS; PATTERNS;
D O I
10.1002/cam4.5955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The role of postoperative radiotherapy (PORT) in malignant pleural mesothelioma (MPM) remains controversial and the eighth edition TNM staging scheme for MPM has not been fully verified. We aimed to develop an individualized prediction model for identifying optimal candidates for PORT among MPM patients who received surgery plus chemotherapy and externally validate the performance of the new TNM staging scheme.Materials and Methods: Detailed characteristics of MPM patients during 2004-2015 were retrieved from SEER registries. Propensity score matching (PSM) was conducted to reduce disparities of baseline characteristics (age, sex, histologic type, stage, and type of surgery) between the PORT group and no-PORT group. A novel nomogram was constructed based on independent prognosticators identified by multivariate Cox regression model. The discriminatory performance and degree of calibration were evaluated. We stratified patients into different risk groups according to nomogram total scores and estimated the survival benefit of PORT in different subgroups in order to identify the optimal candidates.Results: We identified 596 MPM patients, among which 190 patients (31.9%) received PORT. PORT conferred significant survival benefit in the unmatched population, while there was no significant survival difference favoring PORT in the matched population. The C-index of the new TNM staging scheme was closed to 0.5, which represented a poor discriminatory ability. A novel nomogram was constructed based on clinicopathological factors, including age, sex, histology, and N stage. We stratified patients into three risk groups. Subgroup analyses indicated that PORT was beneficial for high-risk group (p = 0.003) rather than low-risk group (p = 0.965) and intermediate-risk group (p = 0.661).Conclusion: We established a novel predictive model, which could make individualized prediction of survival benefit of PORT for MPM and could compensate for weakness in TNM staging system.
引用
收藏
页码:12452 / 12461
页数:10
相关论文
共 50 条
  • [21] Survivin and survival in malignant pleural mesothelioma
    Klabatsa, A
    Steele, J
    Fenneil, D
    Evans, M
    Rudd, R
    Sheaff, M
    LUNG CANCER, 2005, 49 : S222 - S222
  • [22] MALIGNANT PLEURAL MESOTHELIOMA - A SURVIVAL STUDY
    HARVEY, JC
    FLEISCHMAN, EH
    KAGAN, AR
    STREETER, OE
    JOURNAL OF SURGICAL ONCOLOGY, 1990, 45 (01) : 40 - 42
  • [23] Predictors of survival in black and white patients with malignant pleural mesothelioma
    Alpert, Naomi
    van Gerwen, Maaike
    Ohri, Nisha
    Flores, Raja
    Taioli, Emanuela
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [24] Patterns of care and survival of older patients with malignant pleural mesothelioma
    Linton, Anthony
    Blinman, Prunella
    Kao, Steven
    van Zandwijk, Nico
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (04) : 573 - 576
  • [25] Effect of surgical treatment on the survival in patients with malignant pleural mesothelioma
    Baez-Saldana, R.
    Marmolejo-Torres, M. T.
    Iniguez-Garcia, M.
    Berrios Mejia, J. A.
    Rumbo-Nava, U.
    Arrieta-Rodriguez, O.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Improved survival in patients with malignant pleural mesothelioma since 2003
    Serke, M.
    Schoenfeld, N.
    Kollmeier, J.
    Kaiser, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?
    Bovolato, Pietro
    Casadio, Caterina
    Bille, Andrea
    Ardissone, Francesco
    Santambrogio, Luigi
    Ratto, Giovanni Battista
    Garofalo, Giuseppe
    Bedini, Amedeo Vittorio
    Garassino, Marina
    Porcu, Luca
    Torri, Valter
    Pastorino, Ugo
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (03) : 390 - 396
  • [28] The role of radiotherapy in the treatment of malignant pleural mesothelioma
    Waite, K.
    Gilligan, D.
    CLINICAL ONCOLOGY, 2007, 19 (03) : 182 - 187
  • [29] What Is the Role of Radiotherapy in Malignant Pleural Mesothelioma?
    Price, Allan
    ONCOLOGIST, 2011, 16 (03): : 359 - 365
  • [30] THE ROLE OF RADIOTHERAPY IN MALIGNANT PLEURAL MESOTHELIOMA TREATMENT
    Le Pechoux, C.
    Paumier, A.
    Planchard, D.
    Margery, J.
    Ruffie, P.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S31 - S31